Tradename | Company | Number | Date | Products |
---|---|---|---|---|
ACTONEL WITH CALCIUM (COPACKAGED) | Warner Chilcott | N-021823 DISCN | 2005-08-12 | 1 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
actonel | New Drug Application | 2023-10-01 |
atelvia | New Drug Application | 2023-10-20 |
risedronate sodium | ANDA | 2025-04-02 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Osteoporosis | D010024 | EFO_0003882 | M81.0 | 3 | 1 | 5 | 1 | 2 | 12 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postmenopausal osteoporosis | D015663 | EFO_0003854 | — | — | 1 | 3 | — | 1 | 5 |
Metabolic bone diseases | D001851 | — | — | 1 | — | 1 | — | — | 2 |
Osteogenesis imperfecta | D010013 | — | Q78.0 | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Postmenopause | D017698 | — | — | 1 | 2 | — | — | — | 3 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Healthy volunteers/patients | — | — | — | 1 | — | — | — | — | 1 |
Biological availability | D001682 | — | — | 1 | — | — | — | — | 1 |
Infertility | D007246 | EFO_0000545 | — | 1 | — | — | — | — | 1 |
Drug common name | Risedronic acid |
INN | risedronic acid |
Description | Risedronic acid is a member of pyridines. |
Classification | Small molecule |
Drug class | calcium metabolism regulators |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=P(O)(O)C(O)(Cc1cccnc1)P(=O)(O)O |
PDB | — |
CAS-ID | 105462-24-6 |
RxCUI | — |
ChEMBL ID | CHEMBL923 |
ChEBI ID | 8869 |
PubChem CID | 5245 |
DrugBank | DB00884 |
UNII ID | KM2Z91756Z (ChemIDplus, GSRS) |